Author

Bhupesh Vaidya

Baylor College of MedicineORCID 0000-0003-2003-6695Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 4 Research Focus:differential expression· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Huda Yahya ZoghbiiD· 3 shared Young Doo KimiD· 2 shared Ajay Kumar VermaiD· 1 shared Antara A. BanerjeeiD· 1 shared Bakhos Tadros· 1 shared Cameron OstermaniD· 1 shared Femil Joseph Shajan· 1 shared Hari Krishna YalamanchiliiD· 1 shared

Activity by Year

2019-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersNeuroscience

Huda Yahya ZoghbiORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

The CHIP-LMO7-BAG5 complex controls tau clearance and yields repurposed and newly designed therapeutic candidates for Alzheimer's disease

Ji‐Yoen Kim, Bakhos Tadros, Bhupesh Vaidya, Yan Hong Wei Liang, Sung Yun Jung, Xue Deng, Jin Xu, Huda Yahya Zoghbi

The paper identifies the CHIP-LMO7-BAG5 complex as a regulator of tau clearance and develops therapeutic candidates targeting this complex for Alzheimer's disease.

bioRxiv · Jun 29, 2026 · PreprintNeuroscience

Astrocytic ACSBG1 depletion improves lipid-cytokine signaling and attenuates α-Synuclein pathology in a Parkinson's disease mouse model

Young Doo Kim, Bhupesh Vaidya, Jiyoen Kim, Sara Bitar, Femil Joseph Shajan, Ajay Kumar Verma, Hari Krishna Yalamanchili, Shubham Singh, Huda Yahya Zoghbi

This study shows that reducing ACSBG1 in astrocytes reduces inflammation and α-Synuclein pathology in a Parkinson's disease mouse model.

bioRxiv · Jun 8, 2026 · PreprintNeuroscience

GLP-1 analogs restore inflammatory, mitochondrial and intercellular signaling networks in the SncaG51D/G51D knock-in mouse model of Parkinson's disease

Bhupesh Vaidya, Yan Li, Young Doo Kim, Cameron Osterman, Jean‐Pierre Revelli, Huda Yahya Zoghbi

GLP-1 analogs improve motor and non-motor deficits and reduce gliosis and insoluble α-synuclein in a Parkinson's disease mouse model.

bioRxiv · May 19, 2026 · PreprintNeuroscience

Chemogenetic activation of excitatory neurons alters hippocampal neurotransmission in a dose-dependent manner

Sthitapranjya Pati, Sonali S. Salvi, Mamata Kallianpur, Bhupesh Vaidya, Antara A. Banerjee, Sudipta Maiti, James Premdoss Clement, Vidita A. Vaidya

The paper investigates how different doses of CNO affect excitatory neurotransmission in the hippocampus using hM3Dq DREADD activation in mice.

eNeuro · Oct 23, 2019Peer-reviewedNeuroscience